Blog Viewer

Safety, Feasibility, and Efficiency of a New Cooling Device Using Intravenous Cold Infusions for Fever Control

By Currents Editor posted 02-11-2019 14:10


By J. F. Willms, O. Boss, E. Keller


Fever control plays a key role in therapy of patients with acute brain injury. The infusion of cold saline could serve as an alternative or additional method for targeted temperature management. However, it is difficult to estimate the amount of fluid required to achieve normothermia merely on the basis of body weight. There is no standardized load management regarding the administration of cold saline, and no closed-loop systems based on continuous temperature-controlled feedback are available. The primary purpose of the present study was to evaluate the feasibility, efficacy, and safety of a new automated fluid infusion system.


Twelve patients with acute brain injury and febrile episodes were treated with the automated infusion device tempedy (seiratherm GmbH, Herzogenaurach, Germany). Patients were included if bladder temperature still was ≥ 37.9 °C after administration of antipyretic medication, cold washing solutions, and ice packs more than 2 h earlier. The efficacy was examined by measuring the time and amount of fluid needed to reach and maintain target temperature. Feasibility and safety were assessed based on recording any technical difficulties with the new device and the occurrence of clinical signs of fluid overload such as acute pulmonary edema, electrolyte disturbances, or acid–base dysfunction.


The mean time was 73 min (range from 15 to 330 min) and 1650 ml the mean amount of fluid (21.2 ml/kg; SD 28.5 ml/kg) to reach the target temperature. The mean total fluid balance to reach and maintain the target temperature in the first 12 h was 1350 ml (SD 1550 ml). In the first 12 h 89.4% of the time temperature values were in the target range (median 95.3%, range 83.8–10%). No clinical signs of fluid overload such as an acute pulmonary edema or device-related adverse events occurred.


Target temperature management with the new automated infusion device is feasible. Although we provided first data regarding safety, further controlled randomized studies are needed to evaluate the long-time safety, as well as the best indications and timing for this cooling device.

Read more


By Roy Poblete, MD, David Seder, MD, Gene Sung, MD     Since the first Emergency Neurologic Life Support (ENLS) course, there has always been a great deal of interest in developing an advanced learning follow-up course. The Neurocritical Care Society is now proud to present the brand-new ...
The Currents Editorial Board is seeking Stories of Hope submissions for 2020. Stories of Hope tells the stories of patients who have fought their way to recovery and the experiences of their family and/or medical providers. By sharing these stories, we remind each other of what we are all working ...
By Pouya Alexander Ameli, MD, MS Neurocritical Care Fellow, Emory University Chair-Elect, Trainee Section   Naomi Niznick, MD PGY3 Neurology Resident, The Ottawa Hospital Trainee Section Leadership Committee     In Homer’s The Odyssey , Odysseus asks for his friend “Mentor” to watch ...